Synthesis 2017; 49(06): 1319-1326
DOI: 10.1055/s-0036-1588102
paper
© Georg Thieme Verlag Stuttgart · New York

Catalytic Alkylation of 2-Aryl-2-oxazoline-4-carboxylic Acid Esters Using Cyclopeptoids; Newly Designed Phase-Transfer Catalysts

Rosaria Schettini
Dipartimento di Chimica e Biologia ‘A. Zambelli’, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy   Email: iizzo@unisa.it   Email: gdsala@unisa.it
,
Assunta D’Amato
Dipartimento di Chimica e Biologia ‘A. Zambelli’, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy   Email: iizzo@unisa.it   Email: gdsala@unisa.it
,
Francesco De Riccardis
Dipartimento di Chimica e Biologia ‘A. Zambelli’, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy   Email: iizzo@unisa.it   Email: gdsala@unisa.it
,
Giorgio Della Sala*
Dipartimento di Chimica e Biologia ‘A. Zambelli’, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy   Email: iizzo@unisa.it   Email: gdsala@unisa.it
,
Irene Izzo*
Dipartimento di Chimica e Biologia ‘A. Zambelli’, Università degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano (SA), Italy   Email: iizzo@unisa.it   Email: gdsala@unisa.it
› Author Affiliations
Further Information

Publication History

Received: 13 September 2016

Accepted after revision: 27 October 2016

Publication Date:
24 November 2016 (online)


Abstract

Nonionic, chiral macrocyclic peptoids are efficient phase-transfer catalysts in the C-4 enantioselective alkylation of 2-[4-(trifluoromethyl)phenyl]-2-oxazoline-4-carboxylic acid esters. Screening of the structural features of cyclic peptoids, namely the ring size, symmetry elements­, number of proline residues, and substituents on the side chains, showed that the alternated N-(4-methoxybenzyl)glycine/l-proline cyclohexapeptoid is the optimal catalyst (good yields and up to 75% ee) for the stereocontrolled construction of α-alkylated serine tert-butyl esters.

Supporting Information

 
  • References

    • 2a Vogt H, Bräse S. Org. Biomol. Chem. 2007; 5: 406
    • 2b Cabrera S, Reyes E, Alemán J, Milelli A, Kobbelgaard S, Jørgensen KA. J. Am. Chem. Soc. 2008; 130: 12031
    • 2c Zhou J. Org. Chem.: Curr. Res. 2014; 3: e136 ; http://www.omicsonline.org/organic-chemistry-current-research.php
  • 3 O’Donnell MJ, Wu S. Tetrahedron: Asymmetry 1992; 3: 591

    • For recent reviews on asymmetric phase-transfer catalysis see:
    • 4a Jew Ss, Park H.-g. Chem. Commun. 2009; 7090
    • 4b Hashimoto T, Maruoka K. Chem. Rev. 2007; 107: 5656
    • 4c Shirakawa S, Maruoka K. Angew. Chem. Int. Ed. 2013; 52: 4312
    • 4d Tan J, Yasuda N. Org. Process Res. Dev. 2015; 19: 1731
    • 4e Kaneko S, Kumatabara Y, Shirakawa S. Org. Biomol. Chem. 2016; 14: 5367

      For selected examples, see:
    • 5a Corey EJ, Xu F, Noe MC. J. Am. Chem. Soc. 1997; 119: 1414
    • 5b Lygo B, Crosby J, Peterson JA. Tetrahedron Lett. 1999; 40: 8671
    • 5c Lygo B, Crosby J, Peterson JA, Wainwright PG. Tetrahedron 2001; 57: 2403
    • 5d Jew Ss, Jeong BS, Yoo M.-S, Huh H, Park H.-g. Chem. Commun. 2001; 1244
    • 5e Jew Ss, Jeong BS, Lee J.-H, Yoo M.-S, Lee Y.-J, Park B.-s, Kim MG, Park H.-g. J. Org. Chem. 2003; 68: 4514

      For selected examples, see:
    • 6a Ooi T, Takeuchi M, Kameda M, Maruoka K. J. Am. Chem. Soc. 2000; 122: 5228
    • 6b Ooi T, Uematsu Y, Kameda M, Maruoka K. Angew. Chem. Int. Ed. 2002; 41: 1551
    • 6c Kano T, Lan Q, Wang X, Maruoka K. Adv. Synth. Catal. 2007; 349: 556
    • 6d Shirakawa S, Ueda M, Tanaka Y, Hashimoto T, Maruoka K. Chem. Asian J. 2007; 2: 1276
    • 7a Belokon YN, Kochetkov KA, Churkina TD, Ikonnikov NS, Chesnokov AA, Larionov OV, Singh I, Parmar VS, Vyskocil S, Kagan HB. J. Org. Chem. 2000; 65: 7041
    • 7b Belokon YN, North TD, Churkina TD, Ikonnikov NS, Maleev VI. Tetrahedron 2001; 57: 2491
    • 7c Ohshima T, Shibuguchi T, Fukuta Y, Shibasaki M. Tetrahedron 2004; 60: 7743
    • 7d Waser M, Gratzer K, Herchi R, Muller N. Org. Biomol. Chem. 2012; 10: 251
    • 7e Lygo B, Butt U, Cormack M. Org. Biomol. Chem. 2012; 10: 4968
  • 8 Halpern M. Phase Transfer Catalysis. In Ullman’s Encyclopedia of Industrial Chemistry. Vol. 26. Wiley-VCH; Weinheim: 2012: 495
    • 9a Itoh T, Shirakami S. Heterocycles 2001; 55: 37
    • 9b Yonezawa K, Patil ML, Sasai H, Takizawa S. Heterocycles 2005; 66: 639
  • 10 Rapi Z, Grün A, Keglevich G, Stirling A, Bakó P. New J. Chem. 2016; 40: 7856
    • 11a Schettini R, Nardone B, De Riccardis F, Della Sala G, Izzo I. Eur. J. Org. Chem. 2014; 7793
    • 11b Schettini R, De Riccardis F, Della Sala G, Izzo I. J. Org. Chem. 2016; 81: 2494

      For recent reviews on cyclopeptoids:
    • 12a Culf AS, Ouellette R. Molecules 2010; 15: 5282; http://www.mdpi.com/journal/molecules
    • 12b Yoo B, Shin SB. Y, Huang ML, Kirshenbaum K. Chem. Eur. J. 2010; 16: 5528
    • 12c Tedesco C, Erra L, Izzo I, De Riccardis F. CrystEngComm 2014; 16: 3667
    • 13a Maulucci N, Izzo I, Bifulco G, Aliberti A, Comegna D, Gaeta C, Napolitano A, Pizza C, Tedesco C, Flot D, De Riccardis F. Chem. Commun. 2008; 3927
    • 13b Izzo I, Ianniello G, De Cola C, Nardone B, Erra L, Vaughan G, Tedesco C, De Riccardis F. Org. Lett. 2013; 15: 598
    • 13c De Cola C, Fiorillo G, Meli A, Aime S, Gianolio E, Izzo I, De Riccardis F. Org. Biomol. Chem. 2014; 12: 424
    • 14a De Cola C, Licen S, Comegna D, Cafaro E, Bifulco G, Izzo I, Tecilla P, De Riccardis F. Org. Biomol. Chem. 2009; 7: 2851
    • 14b Comegna D, Benincasa M, Gennaro R, Izzo I, De Riccardis F. Bioorg. Med. Chem. 2010; 18: 2010
  • 15 Yamashita T, Iijima M, Nakamura H, Issiki K, Naganawa H, Hattori S, Hamada M, Ishizuka M, Takeuchi T, Iitaka Y. J. Antibiot. 1991; 44: 557
    • 16a Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, Okumoto T. J. Antibiot. 1994; 47: 216
    • 16b Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, Toyama R, Chiba K, Hoshino Y, Okumoto T. J. Antibiot. 1994; 47: 208
    • 16c Strader CR, Pearce CJ, Oberlies NH. J. Nat. Prod. 2011; 74: 900
    • 17a Sasaki S, Hashimoto R, Kiuchi M, Inoue K, Ikumoto T, Hirose R, Chiba K, Hoshino Y, Okumoto T, Fujita T. J. Antibiot. 1994; 47: 420
    • 17b Fujita T, Hamamichi N, Kiuchi M, Matsuzaki T, Kitao Y, Inoue K, Hirose R, Yoneta M, Sasaki S, Chiba K. J. Antibiot. 1996; 49: 846
  • 18 Frązczak O, Lasota A, Leśniak A, Lipkowski AW, Olma A. Chem. Biol. Drug Des. 2014; 84: 199
  • 19 Jew S.-s, Lee Y.-J, Lee J, Kang MJ, Jeong B.-S, Lee J.-H, Yoo M.-S, Kim M.-J, Choi S.-h, Ku J.-M, Park H.-g. Angew. Chem. Int. Ed. 2004; 43: 2382
  • 20 Nakayama K, Maruoka K. Tetrahedron Lett. 2008; 49: 5461
    • 21a Denoël T, Zervosen A, Lemaire C, Joris B, Hervé M, Blanot D, Zaragoza G, Luxena A. Org. Biomol. Chem. 2014; 12: 9853
    • 21b Denoël T, Zervosen A, Lemaire C, Plenevaux A, Luxena A. Tetrahedron 2014; 70: 4526
  • 22 Lee Y.-J, Lee J, Kim M.-J, Kim T.-S, Park H.-g, Jew S.-s. Org. Lett. 2005; 7: 1557

    • For examples of PTC alkylation of related substrates, such as azlactones and oxazol-4(5H)-ones, see:
    • 23a Uraguchi D, Asai Y, Seto Y, Ooi T. Synlett 2009; 658
    • 23b Tarí S, Avila A, Chinchilla R, Nájera C. Tetrahedron: Asymmetry 2012; 23: 176
    • 23c Duan S, Li S, Ye X, Du N.-N, Tan C.-H, Jiang Z. J. Org. Chem. 2015; 80: 7770
  • 24 Lee Y.-J, Lee J, Kim M.-J, Jeong B.-S, Lee J.-H, Kim T.-S, Lee J, Ku S.-s, Jew S.-s, Park H.-g. Org. Lett. 2005; 7: 3207
  • 25 Le Corre L, Gravier-Pelletier C, Le Merrer Y. Eur. J. Org. Chem. 2007; 5386